| Product Name | View Product |
|---|---|
| Artesunate Tablets | View |
| Artesunate, Sulphadoxine and Pyrimethamine Tablets | View |
| Mefloquine & Artesunate Tablets | View |
Artesunate Injection manufacturer in India. Artewel Artesunate Injection wholesale exporter, trader and supplier in India
Most trusted Artesunate Injection manufacturer in India. Order in bulk quantity Artesunate Injection at wholesale rate from India.
Artewel Injection is a trusted, fast-acting solution for treating severe malaria. With Artesunate 120mg, this effective antimalarial works rapidly to clear parasites from the bloodstream, ensuring prompt relief and helping prevent life-threatening complications.
Artewel 120 Artesunate Injection is a quick-acting antimalarial drug that is used to treat severe cases of malaria. Welox Pharma makes it, and it quickly kills malaria parasites and helps people recover quickly in serious cases.
Artewel 120 is available in two various dosages: 60 mg and 120 mg. This is designed to meet the needs of different patients. Hospitals and other healthcare facilities use the injection a lot because it is important to treat malaria quickly.
Welox Pharma is a trusted supplier of Artesunate Injection in India. It makes sure that the product is of high quality, packaged safely, and delivered on time to pharmaceutical distributors, hospitals, and healthcare markets around the world.
We are a trusted artesunate injection exporter from India, supplying superior antimalarial drugs to global healthcare markets that include hospitals, NGOs, and pharmaceutical companies, pharmaceutical wholesalers agencies. Our Artesunate Injection is manufactured in WHO-GMP approved plants with a guarantee of stringent quality, safety, and international pharmaceutical standards to be used effectively in treating severe cases of malaria. We specialize in providing bulk supplies of Artesunate Injection in secure packaging and quick deliveries to international destinations.
The artesunate market is witnessing steady growth owing to the increasing incidences of malaria in tropical and subtropical areas along with growing need for rapid-acting antimalarials. There is increased emphasis by the governments and healthcare providers on using Artesunate-based drugs in emergency protocols that have led to good demand for this drug in Africa, Asia, and other such regions. There are ample market opportunities for pharmaceutical manufacturers and exporters involved in bulk supply and healthcare partnerships.
Beside this well also export in other countries